PRRT2 and Alzheimer disease: Indeed, RACK1 levels have been found to be decreased in post-mortem AD patients’ samples [99,101,133,134]—although discordant data were also reported [135]—suggesting a potential involvement of RACK1 in altered PKC activation associated with dementia.